Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-finding study of BF 2.649 for excessive daytime sleepiness in Parkinson's disease
2007-003512-57Phase 2Completed
- Sponsor
- Bioprojet
- Start
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of pitolisant in Parkinson's disease (PD) and Hypersomnia (HS) (5 arms), sponsored by Bioprojet. Primary endpoint: Epworth Sleepiness Scale scores over 4 weeks. Started Jul 2007; status: completed.
02
Drugs
pitolisant
03
Conditions
Parkinson's disease (PD)Hypersomnia (HS)
Beyond the preview
Go deeper on 2007-003512-57.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003512-57.